CCCC vs CUBE
C4 Therapeutics Inc (CCCC) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CCCC currently screens at market cap $425.7M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CCCC and CUBE stock pages for the full models.
Not investment advice.